Tectonic Therapeutic, Inc. announced positive Phase 1a safety and tolerability results for its lead program TX45 and updated its corporate presentation for investors.
AI Assistant
TECTONIC THERAPEUTIC INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.